Etsy (ETSY) stock surges 11% after Q1 revenue beats estimates at $631.3M and marketplace sales grow for the first time in over two years.
Browsing: News
Western Digital (WDC) stock rallied ~10% Wednesday as Seagate’s earnings beat reassured investors on AI storage demand ahead of WDC’s April 30 report.
General Dynamics (GD) stock rallied 10% after beating Q1 estimates with $4.11 EPS and $13.5B revenue. Marine Systems revenue jumped 21% on submarine demand.
Teradyne (TER) stock dropped 15% despite record Q1 earnings beating estimates by 23%. Investors focused on soft Q2 guidance and margin outlook concerns.
Stock markets declined Wednesday as investors awaited earnings from tech giants and the Federal Reserve’s policy decision with Chair Jerome Powell.
Intel (INTC) stock soars after crushing Q1 earnings expectations with $0.29 EPS. Data center revenue up 22% as CPUs gain traction in AI infrastructure.
Starbucks (SBUX) shares surged 6.8% after Q2 earnings of $0.50 beat estimates. U.S. comp sales rose 7.1% with first traffic growth in three years.
Arm Holdings (ARM) reports Q4 earnings May 6. Stock down 8% but up 80% YTD. Wells Fargo raises target to $220. Analysts expect $0.58 EPS on $1.47B revenue.
Humana (HUM) stock dropped 7% despite beating Q1 earnings estimates as unchanged full-year guidance and lower Medicare Star Ratings disappointed investors.
Mercedes-Benz (MBGn) Q1 profit drops 17% to €1.43B amid 27% China sales decline. U.S. market gains 20% while company maintains full-year outlook.
Adidas (ADS) stock surges 9% after Q1 operating profit hits €705M and sales grow 14% currency-neutral, beating analyst expectations significantly.
Amphenol (APH) shares surge 9% after reporting $7.62B Q1 revenue and issuing Q2 guidance well above analyst expectations. Record orders drive optimism.
BigBear.ai (BBAI) stock rose 10%+ on strong volume before Q1 earnings May 5. Analysts forecast up to 45% upside with targets ranging from $5 to $6.
GE HealthCare (GEHC) stock dropped ~10% after Q1 earnings miss and lowered full-year guidance. Revenue beat expectations despite margin pressures.
AbbVie (ABBV) surged 2.5% premarket after beating Q1 estimates with $2.65 EPS and $15B revenue. Company raises 2026 guidance on strong growth momentum.